CRH Medical (NYSEAMERICAN:CRHM) issued its quarterly earnings data on Wednesday. The company reported $0.02 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.02, Morningstar.com reports. The business had revenue of $32.02 million for the quarter, compared to analysts’ expectations of $31.40 million.
Shares of NYSEAMERICAN CRHM opened at $2.97 on Friday. CRH Medical has a 52 week low of $2.40 and a 52 week high of $4.50.
Several analysts have recently weighed in on the stock. Zacks Investment Research raised shares of CRH Medical from a “sell” rating to a “hold” rating in a report on Wednesday, December 12th. TD Securities reaffirmed a “buy” rating on shares of CRH Medical in a report on Tuesday, January 8th.
COPYRIGHT VIOLATION NOTICE: This piece of content was first published by WKRB News and is the property of of WKRB News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.wkrb13.com/2019/03/15/crh-medical-crhm-announces-quarterly-earnings-results.html.
CRH Medical Company Profile
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.
Read More: Dividend
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.